Results 11 to 20 of about 5,707 (185)

Prolactinomas

open access: yesLa Presse Médicale, 2021
Hyperprolactinemia, defined by a level of serum prolactin above the standard upper limit of normal range, is a common finding in clinical practice and prolactinomas are the main pathological cause. Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including ...
Luiz Eduardo Wildemberg   +2 more
openaire   +2 more sources

Pituitary Tumour Apoplexy as Cause of Death of Simonetta Vespucci, the Venus by Botticelli. [PDF]

open access: yesEndocrinol Diabetes Metab
A reassessment of Simonetta Vespucci, muse of Sandro Botticelli, attributes her long‐mysterious death to a pituitary adenoma. Clinical reinterpretation of historical accounts suggests tumour expansion led to sellar destruction, severe haemorrhage, and pulmonary complications, offering a coherent medical explanation for her sudden death at twenty‐three.
Nardelli D   +3 more
europepmc   +2 more sources

Treatment of Prolactinoma

open access: yesMedicina, 2022
Prolactinomas are the commonest form of pituitary neuroendocrine tumor (PitNET), representing approximately half of such tumors. Dopamine agonists (DAs) have traditionally been the primary treatment for the majority of prolactinomas, with surgery considered the second line.
Inder, Warrick J., Jang, Christina
openaire   +5 more sources

Prolactinoma [PDF]

open access: yesArquivos Brasileiros de Endocrinologia & Metabologia, 2014
Os prolactinomas são os adenomas de hipófise mais comuns e frequentemente afetam mulheres jovens, em faixa etária de fertilidade. A hiperprolactinemia causa hipogonadismo, irregularidade menstrual ou amenorreia em mulheres, níveis baixos de testosterona sérica em homens e infertilidade e disfunção sexual em ambos os gêneros.
Glezer, Andrea, Bronstein, Marcello D.
openaire   +4 more sources

Increased expression of aromatase cytochrome P450 enzyme is associated with prolactinoma invasiveness in post-menopausal women

open access: yesJournal of International Medical Research, 2019
Objectives To investigate the expression levels of aromatase cytochrome P450 enzyme (P450AROM) and related molecules—estrogen receptor-beta (ER-β), Ki-67, and p53—in prolactinoma tumor tissue from pre- and post-menopausal women, and to determine the ...
Yin-Xia Su   +9 more
doaj   +1 more source

Prolactinoma presenting as chronic anaemia with osteoporosis: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Unexplained anaemia is a rare mode of presentation for prolactinoma. We describe a case of a man, with chronic anaemia ascribed to old age.
Hanley John P, MacLean Fergus R
doaj   +1 more source

Co-Morbidity of Pituitary Adenoma and Frontal Convexity Meningioma: A Case Report and Review of the Literature

open access: yesInternational Clinical Neuroscience Journal, 2020
Instruction: The current study reports a woman with pituitary adenoma and frontal convexity meningioma that was detected accidentally. To the best of our knowledge, this case is considered as a rare clinical scenario.
Thi Phuong Hoai Dinh   +2 more
doaj   +1 more source

Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis

open access: yesOpen Chemistry, 2019
Resistance to Dopamine agonists therapy is still a key factor that hinders the clinical treatment of prolactinoma. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets.
Lan Xiaolei   +4 more
doaj   +1 more source

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy

open access: yesIndian Journal of Endocrinology and Metabolism, 2011
Management of prolactinoma in pregnancy is a big challenge for the treating obstetrician as prolactin levels are normally raised in pregnancy and this creates a possibility of missing the diagnosis of prolactinoma.
Sukhwinder Kaur Bajwa   +3 more
doaj   +1 more source

A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas

open access: yesIndian Journal of Endocrinology and Metabolism, 2021
Cabergoline has long been used in the medical management of prolactin-secreting pituitary adenomas. However, there is contradicting and inadequate evidence on the efficacy of cabergoline in achieving radiological and biochemical remission in prolactinoma.
Rakesh Mishra   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy